Vertex Pharmaceuticals
VRTX
VRTX
1,435 hedge funds and large institutions have $96.8B invested in Vertex Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 242 funds opening new positions, 558 increasing their positions, 479 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 1,274 → 1,435 (+161)
1.32% more ownership
Funds ownership: 91.31% → 92.62% (+1.3%)
8% less call options, than puts
Call options by funds: $895M | Put options by funds: $974M
Holders
1,435
Holding in Top 10
41
Calls
$895M
Puts
$974M
Top Buyers
| 1 | +$1.41B | |
| 2 | +$1.14B | |
| 3 | +$286M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$252M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$142M |
Top Sellers
| 1 | -$510M | |
| 2 | -$479M | |
| 3 | -$356M | |
| 4 |
BlackRock
New York
|
-$260M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$180M |